-
1
-
-
0023547926
-
Metabolism and reactions of quinoid anticancer agents
-
Powis G. Metabolism and reactions of quinoid anticancer agents. Pharmacol Ther 1987;35:57-162.
-
(1987)
Pharmacol Ther
, vol.35
, pp. 57-162
-
-
Powis, G.1
-
2
-
-
0034321937
-
Clinical applications of quinone-containing alkylating agents
-
Begleiter A. Clinical applications of quinone-containing alkylating agents. Front Biosci 2000;5:E153-71.
-
(2000)
Front Biosci
, vol.5
-
-
Begleiter, A.1
-
4
-
-
0020021086
-
Hypoxic cell specific chemotherapeutic agents
-
Sartorelli AC. Hypoxic cell specific chemotherapeutic agents. Adv Enzyme Regul 1982;20:233-44.
-
(1982)
Adv Enzyme Regul
, vol.20
, pp. 233-244
-
-
Sartorelli, A.C.1
-
5
-
-
0023902264
-
Therapeutic attack of hypoxic cells of solid tumours: Presidential address
-
Sartorelli AC. Therapeutic attack of hypoxic cells of solid tumours: presidential address. Cancer Res 1988;48:775-8.
-
(1988)
Cancer Res
, vol.48
, pp. 775-778
-
-
Sartorelli, A.C.1
-
6
-
-
0028645493
-
Enzyme-directed bioreductive drug development revisited: A commentary on recent progress and future prospects with emphasis on quinone anticancer drugs and quinone metabolising enzymes, particularly DT-diaphorase
-
Workman P. Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer drugs and quinone metabolising enzymes, particularly DT-diaphorase. Oncol Res 1994;6:461-75.
-
(1994)
Oncol Res
, vol.6
, pp. 461-475
-
-
Workman, P.1
-
7
-
-
0032053823
-
The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy
-
Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 1998;58:1408-16.
-
(1998)
Cancer Res
, vol.58
, pp. 1408-1416
-
-
Brown, J.M.1
Giaccia, A.J.2
-
8
-
-
0027429970
-
Reductive activation of mitomycin C by NADH:cytochrome b5 reductase
-
Hodnick WF, Sartorelli AC. Reductive activation of mitomycin C by NADH:cytochrome b5 reductase. Cancer Res 1993;53:4907-12.
-
(1993)
Cancer Res
, vol.53
, pp. 4907-4912
-
-
Hodnick, W.F.1
Sartorelli, A.C.2
-
9
-
-
0032502684
-
The intracellular location of NADH:cytochrome b5 reductase modulates the cytotoxicity of the mitomycins to Chinese hamster ovary cells
-
Belcourt MF, Hodnick WF, Rockwell S, Sartorelli AC. The intracellular location of NADH:cytochrome b5 reductase modulates the cytotoxicity of the mitomycins to Chinese hamster ovary cells. J Biol Chem 1998;273:8875-81.
-
(1998)
J Biol Chem
, vol.273
, pp. 8875-8881
-
-
Belcourt, M.F.1
Hodnick, W.F.2
Rockwell, S.3
Sartorelli, A.C.4
-
10
-
-
0021345793
-
Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase
-
Pan SS, Andrews PA, Glover CJ, Bachur NR. Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase. J Biol Chem 1984;259:959-66.
-
(1984)
J Biol Chem
, vol.259
, pp. 959-966
-
-
Pan, S.S.1
Andrews, P.A.2
Glover, C.J.3
Bachur, N.R.4
-
11
-
-
0025673868
-
Activation of mitomycin C by NADPH:cytochrome P-450 reductase
-
Bligh HF, Bartoszek A, Robson CN, et al. Activation of mitomycin C by NADPH:cytochrome P-450 reductase. Cancer Res 1990;50:7789-92.
-
(1990)
Cancer Res
, vol.50
, pp. 7789-7792
-
-
Bligh, H.F.1
Bartoszek, A.2
Robson, C.N.3
-
12
-
-
0025688249
-
Metabolism of mitomycin C by DT-diaphorase: Role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells
-
Siegel D, Gibson NW, Preusch PC, Ross D. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res 1990;50:7483-9.
-
(1990)
Cancer Res
, vol.50
, pp. 7483-7489
-
-
Siegel, D.1
Gibson, N.W.2
Preusch, P.C.3
Ross, D.4
-
13
-
-
0025893246
-
The role of NAD(P)H: Quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9
-
Walton MI, Smith PJ, Workman P. The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9. Cancer Commun 1991;3:199-206.
-
(1991)
Cancer Commun
, vol.3
, pp. 199-206
-
-
Walton, M.I.1
Smith, P.J.2
Workman, P.3
-
14
-
-
0027048768
-
Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity
-
Gibson NW, Hartley JA, Butler J, Siegel D, Ross D. Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity. Mol Pharmacol 1992;42:531-6.
-
(1992)
Mol Pharmacol
, vol.42
, pp. 531-536
-
-
Gibson, N.W.1
Hartley, J.A.2
Butler, J.3
Siegel, D.4
Ross, D.5
-
15
-
-
0025917452
-
High levels of expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin
-
Cresteil T, Jaiswal AK. High levels of expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin. Biochem Pharmacol 1991;42:1021-7.
-
(1991)
Biochem Pharmacol
, vol.42
, pp. 1021-1027
-
-
Cresteil, T.1
Jaiswal, A.K.2
-
16
-
-
0026700546
-
Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: Relationship to the response of lung tumor xenografts to mitomycin C
-
Malkinson AM, Siegel D, Forrest GL, et al. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin C. Cancer Res 1992;52:4752-7.
-
(1992)
Cancer Res
, vol.52
, pp. 4752-4757
-
-
Malkinson, A.M.1
Siegel, D.2
Forrest, G.L.3
-
17
-
-
0027268350
-
NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues
-
Belinsky M, Jaiswal AK. NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues. Cancer Metastasis Rev 1993;12:103-17.
-
(1993)
Cancer Metastasis Rev
, vol.12
, pp. 103-117
-
-
Belinsky, M.1
Jaiswal, A.K.2
-
18
-
-
0028783332
-
DT-diaphorase activity in normal and neoplastic human tissues: An indicator for sensitivity to bioreductive agents?
-
Smitskamp-Wilms E, Giaccone G, Pinedo HM, van der Laan BF, Peters GJ. DT-diaphorase activity in normal and neoplastic human tissues: an indicator for sensitivity to bioreductive agents? Br J Cancer 1995;72:917-21.
-
(1995)
Br J Cancer
, vol.72
, pp. 917-921
-
-
Smitskamp-Wilms, E.1
Giaccone, G.2
Pinedo, H.M.3
Van Der Laan, B.F.4
Peters, G.J.5
-
19
-
-
0029997868
-
Enzymology of bioreductive drug activation
-
Ross D, Beall HD, Siegel D, Traver RD, Gustafson DL. Enzymology of bioreductive drug activation. Br J Cancer 1996;74:S1-8.
-
(1996)
Br J Cancer
, vol.74
-
-
Ross, D.1
Beall, H.D.2
Siegel, D.3
Traver, R.D.4
Gustafson, D.L.5
-
20
-
-
0031672124
-
Enzymology of mitomycin C metabolic activation in tumour tissue: Implications for enzyme-directed bioreductive drug development
-
Cummings J, Spanswick VJ, Tomasz M, Smyth JF. Enzymology of mitomycin C metabolic activation in tumour tissue: implications for enzyme-directed bioreductive drug development. Biochem Pharmacol 1998;56:405-14.
-
(1998)
Biochem Pharmacol
, vol.56
, pp. 405-414
-
-
Cummings, J.1
Spanswick, V.J.2
Tomasz, M.3
Smyth, J.F.4
-
21
-
-
0033801337
-
Immunodetection of NAD(P)H: Quinone oxidoreductase 1 (NQO1) in human tissues
-
Siegel D, Ross D. Immunodetection of NAD(P)H: quinone oxidoreductase 1 (NQO1) in human tissues. Free Radic Biol Med 2000;29:246-53.
-
(2000)
Free Radic Biol Med
, vol.29
, pp. 246-253
-
-
Siegel, D.1
Ross, D.2
-
22
-
-
0034877061
-
Overexpression of NAD(P)H:quinone oxidoreductase 1 in human reproductive system
-
Zappa F, Ward T, Butler J, Pedrinis E, McGown A. Overexpression of NAD(P)H:quinone oxidoreductase 1 in human reproductive system. J Histochem Cytochem 2001;49:1187-8.
-
(2001)
J Histochem Cytochem
, vol.49
, pp. 1187-1188
-
-
Zappa, F.1
Ward, T.2
Butler, J.3
Pedrinis, E.4
McGown, A.5
-
23
-
-
0037373090
-
NAD(P)H: Quinone oxidoreductase 1 expression in kidney podocytes
-
Zappa F, Ward T, Pedrinis E, Butler J, McGown A. NAD(P)H: quinone oxidoreductase 1 expression in kidney podocytes. J Histochem Cytochem 2003;51:297-302.
-
(2003)
J Histochem Cytochem
, vol.51
, pp. 297-302
-
-
Zappa, F.1
Ward, T.2
Pedrinis, E.3
Butler, J.4
McGown, A.5
-
24
-
-
0024328012
-
Increased sensitivity of quinone resistant cells to mitomycin C
-
Begleiter A, Robotham E, Lacey G, Leith MK. Increased sensitivity of quinone resistant cells to mitomycin C. Cancer Lett 1989;45:173-6.
-
(1989)
Cancer Lett
, vol.45
, pp. 173-176
-
-
Begleiter, A.1
Robotham, E.2
Lacey, G.3
Leith, M.K.4
-
25
-
-
0026475156
-
The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells
-
Pan SS, Akman SA, Forrest GL, Hipsher C, Johnson R. The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells. Cancer Chemother Pharmacol 1992;31:23-31.
-
(1992)
Cancer Chemother Pharmacol
, vol.31
, pp. 23-31
-
-
Pan, S.S.1
Akman, S.A.2
Forrest, G.L.3
Hipsher, C.4
Johnson, R.5
-
26
-
-
0026505943
-
NAD (P) H:quinone oxidoreductase gene expression in human colon carcinoma cells: Characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity
-
Traver RD, Horikoshi T, Danenberg KD, et al. NAD (P) H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res 1992;52:797-802.
-
(1992)
Cancer Res
, vol.52
, pp. 797-802
-
-
Traver, R.D.1
Horikoshi, T.2
Danenberg, K.D.3
-
27
-
-
0029917028
-
Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: Correlation with sensitivity to mitomycin C and EO9
-
Fitzsimmons SA, Workman P, Grever M, et al. Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9. J Natl Cancer Inst 1996;88:259-69.
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 259-269
-
-
Fitzsimmons, S.A.1
Workman, P.2
Grever, M.3
-
28
-
-
0029929226
-
DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric cancer cell lines
-
Mikami K, Naito M, Tomida A, et al. DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric cancer cell lines. Cancer Res 1996;56:2823-6.
-
(1996)
Cancer Res
, vol.56
, pp. 2823-2826
-
-
Mikami, K.1
Naito, M.2
Tomida, A.3
-
29
-
-
0033709414
-
Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: Implications for enzyme-directed bioreductive drug development
-
Phillips RM, Burger AM, Loadman PM, et al. Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development. Cancer Res 2000;60:6384-90.
-
(2000)
Cancer Res
, vol.60
, pp. 6384-6390
-
-
Phillips, R.M.1
Burger, A.M.2
Loadman, P.M.3
-
30
-
-
0033853035
-
The role of reductive enzymes in the cancer cell resistance to mitomycin C
-
Cummings J. The role of reductive enzymes in the cancer cell resistance to mitomycin C. Drug Resist Updat 2000;3:143-8.
-
(2000)
Drug Resist Updat
, vol.3
, pp. 143-148
-
-
Cummings, J.1
-
31
-
-
0035877252
-
Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones
-
Winski SL, Swann E, Hargreaves RH, et al. Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones. Biochem Pharmacol 2001;61:1509-16.
-
(2001)
Biochem Pharmacol
, vol.61
, pp. 1509-1516
-
-
Winski, S.L.1
Swann, E.2
Hargreaves, R.H.3
-
32
-
-
12144287215
-
Immunohistochemical analysis of NAD(P)H: Quinone oxidoreductase and NADPH cvtochrome P450 reductase in human superficial bladder tumours: Relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapy
-
Basu S, Brown JE, Flannigan GM, et al. Immunohistochemical analysis of NAD(P)H : quinone oxidoreductase and NADPH cvtochrome P450 reductase in human superficial bladder tumours: relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapy. Int J Cancer 2004;109:703-9.
-
(2004)
Int J Cancer
, vol.109
, pp. 703-709
-
-
Basu, S.1
Brown, J.E.2
Flannigan, G.M.3
-
33
-
-
0028097816
-
Unusually marked hypoxic sensitization to indoloquinone EO9 and mitomycin C in a human colon-tumour cell line that lacks DT-diaphorase activity
-
Plumb JA, Workman P. Unusually marked hypoxic sensitization to indoloquinone EO9 and mitomycin C in a human colon-tumour cell line that lacks DT-diaphorase activity. Int J Cancer 1994;56:134-9.
-
(1994)
Int J Cancer
, vol.56
, pp. 134-139
-
-
Plumb, J.A.1
Workman, P.2
-
34
-
-
0028063368
-
DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9
-
Plumb JA, Gerritsen M, Workman P. DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9. Br J Cancer 1994;70:1136-43.
-
(1994)
Br J Cancer
, vol.70
, pp. 1136-1143
-
-
Plumb, J.A.1
Gerritsen, M.2
Workman, P.3
-
35
-
-
0029121481
-
Nicotinamide adenine dinucleotide (phosphate): Quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: Quinone cytotoxicity and selectivity in human lung and breast cancer cell lines
-
Beall HD, Murphy AM, Siegel D, et al. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines. Mol Pharmacol 1995;48:499-504.
-
(1995)
Mol Pharmacol
, vol.48
, pp. 499-504
-
-
Beall, H.D.1
Murphy, A.M.2
Siegel, D.3
-
36
-
-
0032435478
-
A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: Identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent
-
Winski SL, Hargreaves RH, Butler J, Ross D. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent. Clin Cancer Res 1998;4:3083-8.
-
(1998)
Clin Cancer Res
, vol.4
, pp. 3083-3088
-
-
Winski, S.L.1
Hargreaves, R.H.2
Butler, J.3
Ross, D.4
-
37
-
-
0027159001
-
Two structurally related diaziridinylbenzoquinones preferentially cross-link DNA at different sites upon reduction with DT-diaphorase
-
Berardini MD, Souhami RL, Lee CS, et al. Two structurally related diaziridinylbenzoquinones preferentially cross-link DNA at different sites upon reduction with DT-diaphorase. Biochemistry 1993;32:3306-12.
-
(1993)
Biochemistry
, vol.32
, pp. 3306-3312
-
-
Berardini, M.D.1
Souhami, R.L.2
Lee, C.S.3
-
38
-
-
0034609585
-
Sigmatropic reactions of the aziridinyl semiquinone species. Why aziridinyl benzoquinones are metabolically more stable than aziridinyl indoloquinones
-
Xing C, Skibo EB. Sigmatropic reactions of the aziridinyl semiquinone species. Why aziridinyl benzoquinones are metabolically more stable than aziridinyl indoloquinones. Biochemistry 2000;39:10770-80.
-
(2000)
Biochemistry
, vol.39
, pp. 10770-10780
-
-
Xing, C.1
Skibo, E.B.2
-
39
-
-
0033785989
-
Establishment of an isogenic human colon tumor model for NQO1 gene expression: Application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivo
-
Sharp SY, Kelland LR, Valenti MR, et al. Establishment of an isogenic human colon tumor model for NQO1 gene expression: application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivo. Mol Pharmacol 2000;58:1146-55.
-
(2000)
Mol Pharmacol
, vol.58
, pp. 1146-1155
-
-
Sharp, S.Y.1
Kelland, L.R.2
Valenti, M.R.3
-
40
-
-
0344442219
-
Activity profile of the novel aziridinylbenzoquinones MeDZQ and RH1 in human tumour xenografts
-
In Press
-
Cummings J, Langdon S, Butler J, Ward TH, Smyth JF. Activity profile of the novel aziridinylbenzoquinones MeDZQ and RH1 in human tumour xenografts. Anticancer Res. In Press 2003.
-
(2003)
Anticancer Res
-
-
Cummings, J.1
Langdon, S.2
Butler, J.3
Ward, T.H.4
Smyth, J.F.5
-
41
-
-
2442484645
-
Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: Evaluation of the activity of RH1
-
Dehn DL, Winski SL, Ross D. Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1. Clin Cancer Res 2004;10:3147-55.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 3147-3155
-
-
Dehn, D.L.1
Winski, S.L.2
Ross, D.3
-
42
-
-
0033981669
-
Pharmacological properties of a new aziridinylbenzoquinone, RH1 (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone), in mice
-
Loadman PM, Phillips RM, Lim LE, Bibby MC. Pharmacological properties of a new aziridinylbenzoquinone, RH1 (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl- 1,4-benzoquinone), in mice. Biochem Pharmacol 2000;59:831-7.
-
(2000)
Biochem Pharmacol
, vol.59
, pp. 831-837
-
-
Loadman, P.M.1
Phillips, R.M.2
Lim, L.E.3
Bibby, M.C.4
-
43
-
-
21944447905
-
Chemosensitivity, DNA cross linking and enzyme profiling in ovarian tumuor cells derived from patients
-
Ward TH, Richards JT, McGown AT, Butler J. Chemosensitivity, DNA cross linking and enzyme profiling in ovarian tumuor cells derived from patients. Neoplasma 1999;46:52-60.
-
(1999)
Neoplasma
, vol.46
, pp. 52-60
-
-
Ward, T.H.1
Richards, J.T.2
McGown, A.T.3
Butler, J.4
-
44
-
-
0029131331
-
Cross-resistance studies on two K562 sublines resistant to diaziridinylbenzoquinones
-
Ward TH, Haran MS, Whittaker D, et al. Cross-resistance studies on two K562 sublines resistant to diaziridinylbenzoquinones. Biochem Pharmacol 1995;50:459-64.
-
(1995)
Biochem Pharmacol
, vol.50
, pp. 459-464
-
-
Ward, T.H.1
Haran, M.S.2
Whittaker, D.3
-
45
-
-
0030920810
-
Comet assay studies on the activation of two diaziridinylbenzoquinones in K562 cells
-
Ward TH, Butler J, Shahbakhti H, Richards JT. Comet assay studies on the activation of two diaziridinylbenzoquinones in K562 cells. Biochem Pharmacol 1997;53:1115-21.
-
(1997)
Biochem Pharmacol
, vol.53
, pp. 1115-1121
-
-
Ward, T.H.1
Butler, J.2
Shahbakhti, H.3
Richards, J.T.4
-
47
-
-
16744368637
-
United Kingdom Co-ordinating Comittee on Cancer Research (UKCCR) guidelines for the welfare of animals in experimental neoplasia
-
Workman P, Twentyman P, Balkwill F, et al. United Kingdom Co-ordinating Comittee on Cancer Research (UKCCR) guidelines for the welfare of animals in experimental neoplasia. Br J Cancer 1998;77:1-10.
-
(1998)
Br J Cancer
, vol.77
, pp. 1-10
-
-
Workman, P.1
Twentyman, P.2
Balkwill, F.3
-
48
-
-
0025045577
-
Contrasting cytotoxic mechanisms of similar antitumour diaziridinylbenzoquinones
-
Butler J, Dzielendziak A, Lea JS, Ward TH, Hoey BM. Contrasting cytotoxic mechanisms of similar antitumour diaziridinylbenzoquinones. Free Radic Res Commun 1990;8:231-9.
-
(1990)
Free Radic Res Commun
, vol.8
, pp. 231-239
-
-
Butler, J.1
Dzielendziak, A.2
Lea, J.S.3
Ward, T.H.4
Hoey, B.M.5
-
49
-
-
1942503333
-
Cytotoxicity of the bioreductive agent RH1 and its lack of interaction with radiation
-
Kim JY, West CM, Valentine H, et al. Cytotoxicity of the bioreductive agent RH1 and its lack of interaction with radiation. Radiother Oncol 2004;70:311-7.
-
(2004)
Radiother Oncol
, vol.70
, pp. 311-317
-
-
Kim, J.Y.1
West, C.M.2
Valentine, H.3
-
50
-
-
0035097762
-
Stability-indicating HPLC assay and solution stability of a new diaziridinyl benzoquinone
-
Cheung AP, Struble E, Nguyen N, Liu P. Stability-indicating HPLC assay and solution stability of a new diaziridinyl benzoquinone. J Pharm Biomed Anal 2001;24:957-66.
-
(2001)
J Pharm Biomed Anal
, vol.24
, pp. 957-966
-
-
Cheung, A.P.1
Struble, E.2
Nguyen, N.3
Liu, P.4
-
51
-
-
0036660428
-
Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma
-
Spanswick VJ, Craddock C, Sekhar M, et al. Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. Blood 2002;100:224-9.
-
(2002)
Blood
, vol.100
, pp. 224-229
-
-
Spanswick, V.J.1
Craddock, C.2
Sekhar, M.3
-
52
-
-
0034643405
-
The alkaline single cell electrophoresis assay with eight mouse organs: Results with 22 mono-functional alkylating agents (including 9 dialkyl N-nitrosoamines) and 10 DNA crosslinkers
-
Tsuda S, Matsusaka N, Madarame H, et al. The alkaline single cell electrophoresis assay with eight mouse organs: results with 22 mono-functional alkylating agents (including 9 dialkyl N-nitrosoamines) and 10 DNA crosslinkers. Mutat Res 2000;467:83-98.
-
(2000)
Mutat Res
, vol.467
, pp. 83-98
-
-
Tsuda, S.1
Matsusaka, N.2
Madarame, H.3
-
53
-
-
0034661614
-
Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy
-
Link KH, Kornmann M, Butzer U, et al. Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy. Cancer 2000;89:288-96.
-
(2000)
Cancer
, vol.89
, pp. 288-296
-
-
Link, K.H.1
Kornmann, M.2
Butzer, U.3
-
54
-
-
0034109492
-
Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer
-
Konecny G, Crohns C, Pegram M, et al. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer. Gynecol Oncol 2000;77:258-63.
-
(2000)
Gynecol Oncol
, vol.77
, pp. 258-263
-
-
Konecny, G.1
Crohns, C.2
Pegram, M.3
-
55
-
-
0033367019
-
Chemosensitivity testing of primary tumor cells from gastric cancer patients with liver metastasis can identify effective antitumor drugs
-
Kurihara N, Kubota T, Furukawa T, et al. Chemosensitivity testing of primary tumor cells from gastric cancer patients with liver metastasis can identify effective antitumor drugs. Anticancer Res 1999;19:5155-8.
-
(1999)
Anticancer Res
, vol.19
, pp. 5155-5158
-
-
Kurihara, N.1
Kubota, T.2
Furukawa, T.3
-
56
-
-
4644273680
-
Comet assay and flow cytometry analysis of DNA repair in normal and cancer cells treated with known mutagens with different mechanisms of action
-
Suggitt M, Fearnley J, Swaine DJ, et al. Comet assay and flow cytometry analysis of DNA repair in normal and cancer cells treated with known mutagens with different mechanisms of action. Teratog Carcinog Mutagen 2003;Suppl 2:13-29.
-
(2003)
Teratog Carcinog Mutagen
, Issue.2 SUPPL.
, pp. 13-29
-
-
Suggitt, M.1
Fearnley, J.2
Swaine, D.J.3
|